Your browser doesn't support javascript.
loading
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial.
Daver, Naval G; Dail, Monique; Garcia, Jacqueline S; Jonas, Brian A; Yee, Karen W L; Kelly, Kevin R; Vey, Norbert; Assouline, Sarit; Roboz, Gail J; Paolini, Stefania; Pollyea, Daniel A; Tafuri, Agostino; Brandwein, Joseph M; Pigneux, Arnaud; Powell, Bayard L; Fenaux, Pierre; Olin, Rebecca L; Visani, Giuseppe; Martinelli, Giovanni; Onishi, Maika; Wang, Jue; Huang, Weize; Green, Cherie; Ott, Marion G; Hong, Wan-Jen; Konopleva, Marina Y; Andreeff, Michael.
Afiliação
  • Daver NG; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Dail M; Genentech, Inc, South San Francisco, CA.
  • Garcia JS; Dana-Farber Cancer Institute, Boston, MA.
  • Jonas BA; University of California Davis Comprehensive Cancer Center, Sacramento, CA.
  • Yee KWL; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Kelly KR; Division of Hematology, University of Southern California, Los Angeles, CA.
  • Vey N; Hematologie Clinique, Institut Paoli-Calmettes, Marseille, France.
  • Assouline S; Jewish General Hospital, Montreal, QC, Canada.
  • Roboz GJ; Weill Cornell Medical College, New York Presbyterian, New York, NY.
  • Paolini S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli," Bologna, Italy.
  • Pollyea DA; Division of Hematology, School of Medicine, University of Colorado, Aurora, CO.
  • Tafuri A; Hematology, Department of Clinical and Molecular Medicine, University Hospital Sant'Andrea-Sapienza, Rome, Italy.
  • Brandwein JM; Division of Hematology, University of Alberta, Edmonton, AB, Canada.
  • Pigneux A; Bordeaux Haut-Lévêque University Hospital, Pessac, France.
  • Powell BL; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC.
  • Fenaux P; Hôpital Saint-Louis, Université Paris Diderot, Paris, France.
  • Olin RL; University of California San Francisco, San Francisco, CA.
  • Visani G; Hematology, Ospedale San Salvatore, Pesaro, Italy.
  • Martinelli G; IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori," Meldola, Italy.
  • Onishi M; Genentech, Inc, South San Francisco, CA.
  • Wang J; Genentech, Inc, South San Francisco, CA.
  • Huang W; Genentech, Inc, South San Francisco, CA.
  • Green C; Genentech, Inc, South San Francisco, CA.
  • Ott MG; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Hong WJ; Imago BioSciences, South San Francisco, CA.
  • Konopleva MY; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Andreeff M; Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Blood ; 141(11): 1265-1276, 2023 03 16.
Article em En | MEDLINE | ID: mdl-36265087
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos